The findings underscore the importance of urine testing before starting treatment and considering alternative treatments.
US healthcare facilities saw a spike in cases and transmission of the deadly, multidrug-resistant yeast in 2020 and 2021.
After adjustment for risk factors, adherence to clinical guidelines was identified as a major protective factor.
Risk factors include receiving intubation, a central venous line, or a drain, plus receipt of antifungal drugs within 7 days of admission.
An FDA committee recommends approval of rezafungin for the treatment of candidemia and invasive candidiasis in adults.
Analysis of wastewater isolates revealed phylogenetic relatedness to isolates from three acute-care hospitals in the same watershed.
The survey shows a near doubling of C auris cases—and countries reporting them.
Despite limited data, new WHO report highlights 19 fungi that represent the greatest threat to public health.
The World Health Organization (WHO) today announced the release of the first global framework on the responsible use of life sciences, which addresses the accidental or deliberate misuse of biologic and other life sciences, including dual-use research.
Data from a healthcare-associated infection (HAI) surveillance network in India shows high rates of bloodstream and urinary tract infections (UTIs) and very high levels of antibiotic resistance, researchers reported in The Lancet Global Health.
